Biopharmaceutical Company Expands Clinical Trials On Texas A&M-Developed Angelman Syndrome Treatment
The disorder leads to developmental delay, speech impairment, movement or balance disorders, and seizures.
Source: tamu.edu
Stay updated with breaking news from Generating Excellence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The disorder leads to developmental delay, speech impairment, movement or balance disorders, and seizures.